Henoch-Schonlein Purpura: Presentation Patterns
in Arab children in Kuwait
.........................................................................................................................
Mohammed M. Tohmaz,
Samir I Saleh, Fahed AL-Anezi
Correspondence
to:
DR FAHAD ALANEZI,
Department of pediatrics,
Al-Jahra Hospital, Kuwait.
Tel: 9659846919 Email: fdh529@hotmail.com
.........................................................................................................................
|
ABSTRACT
Background:
Henoch-Schonlein purpura is an IgA-mediated,
autoimmune, hypersensitivity vasculitis
of childhood characterized by purpuric
rash occurring on the lower extremities,
abdominal pain, arthritis and renal involvement.
Although of unknown cause, HSP is often
associated with infectious agents, food
reactions, exposure to cold, insect bites
and drug allergens. Ethnic variations
of the rare childhood vasculitides are
not well characterized. Our aim was to
ascertain the incidence and presentation
pattern in Arab children in Kuwait.
Patients
and methods: Forty-four Arab children
of 2-12 years old were included in this
study. Detailed history was obtained,
and through clinical examination was performed.
Laboratory, as well as, imaging evaluation,
was done.
Interpretation:
Henoch-Schonlein purpura occurred more
frequently among Arab children. The incidence
was 0.3%. All patients presented with
purpuric rash. Arthritis was present in
36.4%, and abdominal pain in 25% of cases.
Renal involvement was rare. It occurred
in 9% of cases. In contrary bleeding per
rectum was common, it occurred in 20.4%
of cases.
|
Keywords:
Purpura, Henoch-Schonlein, systemic vasculitis
of childhood, IgA-associated nephropathy, arthritis,
abdominal pain.
..........................................................................................................................
This
small- vessel vasculitis is most commonly seen
in children. It is associated with abdominal
pain and an acute arthritis affecting one or
more joints at a time (1). Boys are affected
twice as frequently as girls (2). It has an
incidence of 14 per 100,000 children and occurs
most frequently in spring and fall (3). Pulpable
non-thrombocytopenic purpura is found characteristically
over buttocks and lower legs, and up to half
the children affected have angio-edema. Intussusception,
rectal bleeding and renal involvement are features
of more severe disease. Fewer than 54% of patients
have acute renal insufficiency (4), and another
5% have slow progression with renal failure
developing months to years later (5).
The
skin lesions and the renal glomeruli may contain
IgA immune complexes, which likely are formed
in response to an inciting factor; most probably
Parvovirus B19 (6). However the disease can
occur secondary to other infectious agents,
food reactions, exposure to cold, insect bites
and drug allergies.
Ethnic differences in the incidence of childhood
diseases are well recognized, and have been
described for several conditions. Recognition
of ethnic differences in incidence rates of
rare conditions such as vasculitis, helps to
identify the cause and directs the investigations.
It can, as well, help in the planning of health
services, and identification of outcome of these
conditions.
The
aim of this study was to find out the incidence
and identify the presentation pattern of Henoch-Schonlein
purpura (HSP) among Arab children in Kuwait.
Forty-four
Arab children with Henoch-Schonlein purpura
were included in this study. A child is considered
to have HSP if he fulfils three or more out
of the criteria of The American College of Rheumatology
for the classification of Henoch-Schonlein purpura
(1). Detailed history was obtained. History
of recent drug ingestion and food consumption
was ascertained. Abdominal pain and gastric
hemorrhage had also been reported, as well as
seizure activity. Full physical examination
was performed. Skin rash, arthritis, throat
congestion, palpable abdominal masses and signs
of cardiac involvement were looked for and blood
pressure was recorded.
Laboratory
evaluation was done. This included CBC, ESR,
LFT, PT & PTT, RFT, urinalysis, and stool
for occult blood. Serum samples for C3, C4,
ANA, ds DNA and rheumatoid factor were collected.
Ultra-sound abdomen was done in patients with
abdominal pain. Renal biopsy was done in one
case because of hematuria, heavy proteinuria
and elevated blood pressure. Upper gastro-intestinal
endoscopy was done in another case because of
hematemesis.
Over a period of 2 years
from January 2005 to December 2006; out of 16,903
admissions to Pediatric Department, Jahra Hospital
44 (0.3%) children had Henoch-Schonlein purpura.
Twenty were males and 24 were females with a
male to female ratio of 1:1.2 (Table 1). Their
ages ranged from 2-12 years. The incidence was
highest between 6 and 8 years (Figure 1), with
a mean age of 6 years & 8 months. The mean
age of male patients was 7 years (range 2.5-11
years.) and that of the females 6.5 yrs. (range
2-12 years). Twelve patients (27.2%) had recurrent
attacks of HSP; 2 of them had more than one
attack (Table 1).
All patients had purpuric
skin rash mainly involving both lower limbs
(Table 2). Arthritis was found in 16 (36.4%)
patients, and abdominal pain in 11 (25%) patients.
Six (13.6%) patients were edematous and only
one (2.3%) patient had hypertension. Table 3
summarizes the clinical data.
Hematuria and proteinuria
were present in 6 (13.5%) patients. Acute phase
reactants were elevated in 25 (57%) patients
and stools were positive for blood in 11 (25%)
patients. Virology studies were positive in
11 (25%) cases; 2 Parvovirus, 1 EBV and 2 Adenovirus.
Ultrasound abdomen was
normal in all patients. Renal biopsy showed
minimal change; glomerulonephritis in one patient
and gastroscopy revealed duodenitis with micro
ulcers in another patient.
Henoch-Schonlein purpura
is an acute vasculitis that affects children
rarely. The etiology remains unknown, however
circulating IgA immune complexes play a critical
role in the pathogenesis of the disease. The
prevalence of HSP peaks in children aged 3-10
years. It occurs twice as often in males as
in females (7). Genetic contribution to childhood
illness is likely to be increasingly recognized
as our knowledge of the human genome becomes
more sophisticated (8). Gander et al (2) noted
important ethnic differences in the incidence
rates for all childhood primary vasculitids.
Their findings suggest a higher incidence of
HSP in children below 14 years than, the 13.5-18/100,000,
previously estimated (9, 10). They also found
that the incidence rate of HSP was lower in
blacks than any other population, a finding
previously reported in black Americans (11).
By comparison, results of a UK survey suggest
an overall annual incidence of 1.9/100,000 in
young children (12). In our study, we estimated
an incidence of 0.3% (260/100,000), indicating
that HSP among Arab Children may be more frequent.
However, our incidence rate was among diseased
children admitted to the hospital, not among
the childhood population. The prevalence of
the disease in our patients was similar to that
found by others. It peaked in children aged
6-8 years (Figure1), but the male to female
ratio was almost equal, 1:1.2.
Dermatological findings
are notable in HSP. The rash is usually symmetrical
and purpuric. It typically involves lower extremities
and buttocks (13). In more severe cases, hemorrhagic
or necrotic lesions may be prominent (14). All
our cases presented with purpuric skin rash
that involved lower limbs and buttocks. However,
we noticed that the rash tends to be more generalized
in children less than 4 years (Table 2), contrary
to the findings of others who reported mild
illness in infants and young children (7, 15,
16).
Joint symptoms occur
in 70-85% of cases (17). They precede the rash
in 25% of cases. Joints are warm, tender and
swollen. In one study in Thailand, joints were
affected in 42.6% of cases of childhood Henoch-Schonlein
purpura (Pabunruang, 2002). In our study, only
36% of patients had arthritis. This may be due
to ethnic susceptibility as gene polymorphism
may contribute to the diversity of clinical
responses to inflammatory stimulation.
The most serious sequelae
of HSP is renal involvement. It occurs in 50%
of older children, and 25% of children younger
than 2 years (18, 19, 20). In our patients,
only 4 (9%) presented with renal involvement;
one (2.2%) of them had hypertension. Renal function
was normal in all. This may be due to the fact
that Arab children are less susceptible to renal
involvement during the course of the disease.
Other authors also reported ethnic differences
for nephritis in HSP (21).
Gastro-intestinal manifestations,
the commonest second manifestation of HSP, occur
in more than 50% of cases and usually consist
of colicky abdominal pain, melena, or bloody
diarrhoea (22, 23). Hematemesis occurs less
frequently. In our study, 11 (25%) patients
had abdominal pain, 9 (20.4%) had bleeding per
rectum, and one (2.2%) had hematemesis.
From the previous discussion,
we can assume that ethnic differences play a
role in susceptibility to HSP, as well as its
presentation pattern. However, any estimates
must be tentative as less severe cases may be
missed. Also these differences may be secondary
to differences in associated provocative or
inducing factors among locations.
-
Mills
J, Michel B, Bloch D et al. The American
College of Rheumatology 1990: Criteria
for the classification of Henoch-Schonlein
purpura. Artheritis Rheum. 1990; 33:
1114-112
- Gander-Medwin
JM, Dolezalova P, Cummins C, Southward TR:
Incidence of Henoch-Schonlein purpura, Kawasaki
disease and rare vasculitides in children
of different ethnic origins. Lancet 2002;
19, 360 (9341): 1197-202.
-
Trujillo
H, Gunasekaran TS, Eisenberg GM, Pojman
D, Kallen R: Henoch-Schonlein purpura:
a diagnosis not be forgotten. J Fam
Pract 1996; 43:495-8.
-
Goldstein
A, White R, Akuse R et al: Long- term
follow-up of childhood Henoch-Schonlein
nephritis. Lancet. 339: 280, 1992.
-
Kakuy,
Noharak, Honda S: Renal involvement
in Henoch-Schonlein purpura: a multivariate
analysis of prognostic factors. Kidney
Int. 1988: 53 (6): 1755.
-
Cloc
AM, Sedmak DD, Nuovo GJ et al: Parvovirus
B19 associated adult Henoch-Schonlein
purpura. J Cutan Pathol. 2002; 29 (10):
602-7.
-
Jannette
JC, Falk RJ: Small vessel vasculitis.
N Engl J Med. 1997; 1512-23.
-
Jimenez-Sanchez
G, Childs B, Valle D: Human disease
genes. Nature. 2001; 409: 853-55.
-
Stewart
M, Savage JM, Bell B, MC Cord B: Long
term renal prognosis of Henoch-Schonlein
purpura in unselected childhood population.
Eur J Pediatr. 1988; 147: 113-15.
-
Neilsen
HE: Epidemiology of Schonlein-Henoch
purpura. Acta Pethol Scand. 1988; 77:
125-31.
-
Galla
JH, Kohaut EC, Alexander R. Racial differences
in the prevalence of IgA-associated
nephropathies. Lancet. 1984; 2: 522.
-
Watts
RA, Lane SE, Bentham G, Scott DGI. Epidemiology
of systemic vasculitis: a ten-year study
in the United Kingdom. Arthritis Rheum.
2000; 43: 414-19.
-
Behrman
RE, Kliegman RM, Jenson HB, eds. Nelson
Textbook of Pediatrics. 17th ed. Philadelphia:
Saunders, 2004; chapter 157, pp 826-28.
-
Debram
Kraft, Denise Mc Kee & Carol Scott:
Henoch-Schonlein purpura: A review.
American Family Physician.
1998 (August); 58 (2): 405-8.
-
Amitai
Y, Gillis D, Wasserman D, Kockman R:
Henoch-Schonlein purpura in infants.
Pediatrics. 1993; 92: 865-7.
-
Ansell
BM, Falceni F: Cutaneous vasculitis
in children. Clin Dermatology. 1999;
17: 577-80.
-
Schumacher
HR: Primer on the rheumatic diseases.
19th ed. Atlanta Ga. Artheritis Foundation,
1988: 1404-5.
-
Piette
WW: The differential diagnosis of purpura
from a morphologic perspective. Adv
Dermatol. 1994; 9: 3-23.
|